http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010075185-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dc365d0d4cf537a503859144cd924ad6
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01D2311-04
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01D69-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01D61-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01D61-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01D61-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01D61-16
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12M1-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01D61-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01D21-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01D61-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12M1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01D61-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01D61-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01D61-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01D69-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-10
filingDate 2009-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0549fe55dab8039a40e34c2d0704097c
publicationDate 2010-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2010075185-A
titleOfInvention Purification and concentration of synthetic biomolecules
abstract The present invention provides a method for purification and concentration by biofiltration of biomolecules produced by synthesis of oligonucleotides, synthetic DNA, synthetic RNA, and the like. An ultrafiltration (UF) membrane having a nominal molecular weight cutoff (NMWCO) of about 0.5 KD to about 10 KD and having a positive or negative charge on the surface of the membrane 4 is used, and the charged surface is used. Then, the synthetic biomolecule is bounced back and held in the remaining liquid, or the synthetic biomolecule is purified and concentrated by preferentially sucking the synthetic biomolecule through membrane filtration. [Selection] Figure 2
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020203142-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016513973-A
priorityDate 2003-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S62106099-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2001502005-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2000513580-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410507374
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44263835

Total number of triples: 36.